* 中国疫苗生产商--康希诺A股688185.SS周四早盘涨幅扩大至4.1%，创3月3日以来新高；其H股6185.HK高开2.5%，随后涨6.6%，创2月28日以来新高。
* 该公司此前公告称，国家药品监督管理局同意重组三价脊髓灰质炎疫苗开展预防由脊髓灰质炎I型、II型和III型病毒感染导致的脊髓灰质炎的临床试验。
* 康希诺H股今年迄今劲涨26.7%，同期恒生指数.HSI大幅上扬22.8%。
* 恒生香港上市生物科技指数.HSHKBIO盘中一度升4.2%。（完）
更多股市简讯请点选CN-CMN-HOT
(发稿 徐凯文；审校 杨淑祯)
((kaiwen.xu@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.